Patent · US Active

Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators

US9464062B2 · kind B2 · utility

3Cited by

3References

14Claims

0Family size

Assignee

Temple University-Of The Commonwealth System of Higher Education · US

Inventors

Daniel J. Canney · Ambler, US
Richie R. Bhandare · Jamkhed, IN
Benjamin E. Blass · Eagleville, US
Magid A. Abou-Gharbia · Wilmington, US

Key dates

Filing date	Nov 26, 2013
Grant date	Oct 11, 2016
Priority date	—
Expiry date	Nov 26, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/06
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Pharmaceutical compositions of the invention comprise disubstituted oxazolidin-2-ones derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 2b activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.